The DNA sequencing market, valued at USD 10.1 billion in 2022, is projected to reach USD 40.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 15.3% from 2023 to 2032. This substantial growth is driven by the increasing application of next-generation sequencing (NGS) technologies, which offer high.
DNA Sequencing Market Is Expected To Progress at a CAGR of 15 3% to Reach US$ 40 5 Billion by 2032 | Market us forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
The Ngs Based Diagnostics Market To Grow Through Partnerships Amongst Market Participants
Ngs Based Diagnostics Market 5
The healthcare vertical is being driven at the consumers’ pace like never before. In other words, the requirements and goals on their part are driving innovation in every arm of the healthcare vertical. On-demand interactions between clinicians and patients all over the world are being asked for. As such, the healthcare vertical is bound to witness higher strides in the next 10 years. The Ngs Based Diagnostics Market is all set to incorporate the ongoing as well as future trend.
Next generation sequencing (NGS) based diagnostics are the medical devices used for diagnosis of various conditions using advanced generation sequencing platforms. They are unique from their earlier versions of first-generation dideoxy ‘Sanger’ sequencing and can perform parallel sequencing of several genomes simultaneously using a single instrument in less than two weeks. Their